|

HRS-4508 Clinical Trials

2 actively recruiting trials

▲ +1 trial since August 2026

Pipeline

Phase 1: 1Phase 2: 1

Top Sponsors

  • Jiangsu HengRui Medicine Co., Ltd.1
  • Fudan University1

Indications

  • Cancer2
  • Hormone Receptor Negative Tumor1
  • Hormone Receptor Positive Tumor1
  • Locally Advanced Breast Cancer1
  • Breast Tumors1

Other2 trials

A Clinical Study of the Safety, Tolerability, Pharmacokinetics, and Initial Efficacy of HRS-4508 Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Phase 1
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.